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Laparoscopic-assisted treatment of abdominal
aortic aneurysm requiring suprarenal cross-clamping
Mauro Ferrari, MD,a Daniele Adami, MD,a Raffaella Berchiolli, MD,a Andrea Del Corso, MD,a and
Andrea Pietrabissa, MD, FACS,b Pisa, Italy
Objective: Hand-assisted laparoscopic surgery (HALS) was previously employed to treat patients with infrarenal
abdominal aortic aneurysm (IAAA). The use of HALS for juxtarenal abdominal aortic aneurysm (JAAA) has never been
validated. In this study, we report our experience with this technique to demonstrate its feasibility and prove its safety in
dealing with JAAA.
Methods: From October 2000 to October 2008, we have selectively treated 271 patients with abdominal aortic aneurysm
with theHALS technique. Of these, 83 were JAAAs which required a suprarenal aortic clamping (group A), and 188were
IAAA (group B). General data of the two groups were analyzed for comparability purposes and operative and
postoperative data were prospectively collected. Additionally, patients in group Awere stratified in three classes according
to their pre-existing degree of renal function impairment. Statistical significance was defined at the P < .05 level.
Results: Mean operative time was 220 minutes  66 in group A and 231 minutes  64 in group B (P > .05). The mean
duration of suprarenal clamping was 28 minutes  6; whereas infrarenal clamping lasted an average of 25 minutes  5
(P > .05). Mean intraoperative blood loss was 1023  584 mL for group A and 961  633 mL for group B (P > .05).
No conversion or 30-day postoperative mortality was recorded in either group. Sixteen percent of the patients in group
A developed a postoperative complication, vs 11% in group B (P > .05). Mean postoperative stay for group A and B was
4.2  1.5 and 4.2  1.9 days, respectively (P > .05). Postoperative kidney function significantly worsened in 5 patients
in group A (6%). A prolonged warm ischemia time (>40), pre-existing renal dysfunction, and diabetes, correlated to the
development of postoperative renal insufficiency. Follow-up of patients averaged 37.9  20 months. The incidence of
incisional hernias in group A and B was 15.5% vs 11.1%, respectively (P > .05).
Conclusion: The HALS technique proved to be feasible and safe not only for patients with IAAA, but also for the
management of patients with JAAA. No significant difference could be shown in the comparison between the two groups,
apart from the expected higher rate of postoperative renal dysfunction after suprarenal clamping. In view of the
demonstrated benefit of this minimally invasive approach, we believe that it should be included among the alternative
options of treatment for these patients. ( J Vasc Surg 2009;50:1006-11.)Over the past 5 years, the number of elective open
surgical repairs for abdominal aortic aneurysm (AAA) pro-
gressively decreased in favor of endovascular aneurysm
repair (EVAR) exclusion, which is now the treatment of
choice in about half of the patients.1-4 Minimally invasive
surgery, in dedicated centers, plays an intermediate role
between the open approach and EVAR.5,6 Pure laparos-
copy or laparoscopic-assisted techniques were introduced
to improve the perioperative outcome of open surgery by
reducing the trauma of access, obviating at the same time
the drawbacks and long-term sequelae of EVAR.5-11 Still,
the shortage of comparative data makes any objective eval-
uation of the various available techniques uneasy, and se-
lection of patients to one treatment or the other often
reflects local expertise or the availability of a given technol-
ogy, rather than established indications. The recent intro-
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1006duction of fenestrated endoprostheses has further compli-
cated this picture, providing a new endovascular option also
for AAA with necks shorter than 1 cm, the so-called juxta-
renal abdominal aortic aneurysm (JAAA).12 Although this
type of aneurysm is still considered a good indication to
open surgery by most vascular surgeons,3 nonetheless
promising results have also been reported with the endo-
vascular repair of JAAA.13,14
Hand-assisted laparoscopic surgery (HALS) has been
shown to be of value in the treatment of selected patients in
general surgery,15 urology,16 and vascular surgery.17 With
HALS, the surgeon has the capability to regain tactile
feedback and finger dissection and to retract and expose
tissues with the nondominant hand as in open surgery, still
retaining most of the benefit of pure laparoscopic surgery.
The potential of this approach in the treatment of AAA has
already been reported by our group and others.8,18
However, the technical challenge posed by JAAA makes
all laparoscopic options less likely to be successful in
dealing with a short aneurysmal neck and suprarenal
cross-clamping.
The purpose of this study was to prove the feasibility
and assess the value of HALS as a surgical option to treat
JAAA in need of suprarenal aortic cross-clamping. Prospec-
tive data were collected from patients undergoing elective
HALS treatment of JAAA and compared to those with
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on by the same technique.
Our data was further analyzed in view of the results
reported in the medical literature with two other minimally
invasive treatments of JAAA: pure laparoscopy and fenes-
trated endografting.
MATERIALS AND METHODS
From October 2000 to October 2008, 972 patients
with AAA were treated in election at the Division of Vas-
cular Surgery of the University of Pisa, using a conventional
open approach in 132 patients (13.6%), EVAR in 208
(21.4%), a left retroperitoneal approach in 163 (16.7%), a
minilaparotomic technique in 198 (20.4%), and with the
HALS technique in 271 (27.8%).
In 83 patients of this last subgroup (36.6%), a supra-
renal aortic cross-clamping was employed due to the
presence of a short neck in 75 patients (90.4%) defined as a
distance between the origin of the aneurysm and the renal
artery shorter than 1 cm, or to manage an aortic neck of
poor quality, mechanically unsuitable for infrarenal cross-
clamping as in 8patients (9.6%).Themean lengthof the aortic
neck in these patients was 4.6  2 mm. These 83 patients
formed group A of this study, whereas group B consisted of
the remaining 188 patients, in whom the HALS technique
was still adopted, but without suprarenal aortic cross-
clamping. The mean length of the aortic neck in group B
Fig. Operative setting for the HALS technique.was 26.3  8 mm.Our technique for the HALS treatment of IAAA has
already been described.18 In case of JAAA, after blunt
finger dissection of the aortic neck, a special self-retracting
system was applied to displace the left renal vein upwards
and facilitate both vision and clamp positioning above the
renal arteries (Fig). The remaining phases of the procedure
are similar to what was already described for the HALS
approach in patients with IAAA.18
General data and associatedmorbidity of patients in the
two groups are depicted in Tables I and II, respectively.
Patients in group A had a higher incidence of hypertension
and impaired renal function, but the existence of no statis-
tical difference for most of the indicated variables makes the
two groups comparable. We have further divided 14 pa-
tients in group A (16.8%) with impaired renal function
(creatinine 1.25 mg/dL) in three classes:19,20
Class a: mild dysfunction (creatinine between 1.25-1.5
mg/dL): 5 patients;
Class b: moderate dysfunction (creatinine between 1.5-2
mg/dL): 6 patients;
Class c: severe dysfunction (creatinine 2 mg/dL): 3
patients.
A bifurcated aortic graft was implanted in 22 patients
Table I. Comparison of general data of patients in group
A (suprarenal aortic cross-clamping) vs patients in group
B (infrarenal aortic cross-clamping)
Variable Group A Group B P value
Number of patients 83 188
Mean age 71  7 69  7 .922
Percentage of males 98% 97% .904
Mean size of AAA (cm) 5.7 5.5 .859
ASA status 1 & 2 40.4% 37.2% .715
ASA status 3 & 4 69.6% 62.8% .329
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiology.
Table II. Comparison of associated morbid conditions
of patients in group A (suprarenal aortic cross-clamping)
vs patients in group B (infrarenal aortic cross-clamping)
Group A Group B P value
Number of patients 83 188
Hypertension 69.3% 51.7%  .05
Ischemic cardiac disease* 37.1% 26.9% .413
COPD 27.4% 30.7% .689
Hyperlipidemia 25.8% 22.4% .716
Obesity (BMI 30) 14.5% 14.7% .930
Diabetes 4.8% 5.7% .604
Renal dysfunction
(creatinine 1.25 mg/dL) 16.8% 8.3%  .05
COPD, Chronic obstructive pulmonary disease; BMI, body mass index.
Chronic obstructive pulmonary disease diagnosed after static and dynamic
evaluation of respiratory function.
*Ischemic cardiac disease: previous myocardial infarction, previous myocar-
dial revascularization (bypass or stent), myocardial ischemia under medical
treatment.(26.5%) in group A to treat a concomitant iliac aneurysm
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A (3.6%) and 2 in group B (1%) an aorto-bifemoral bypass
was performed to manage an occlusive disease of the iliac
arteries. In all the other patients, repair of the aneurysmwas
achieved with an aorto-aortic graft. An autologous blood
recovery system was routinely employed, and blood trans-
fusions were given when needed. Postoperative analgesia
with continuous intravenous infusion of morphine was
used in all patients for the first 8 hours after surgery;
additional shots of ketorolac were given upon request and
recorded.
Operative time, blood loss, and duration of aortic cross-
clamping were prospectively recorded for both groups, to-
gether with the following outcome measures:
- Operative (30-day) mortality;
- Time spent in the intensive care unit (ICU);
- Occurrence and type of complication;
- Time for resumption of a solid diet;
- Need for parenteral support defined as more than 500
mL of fluid infusion/day;
- Need for additional postoperative analgesia;
- Hospital stay.
Serum creatinine was checked postoperatively at 12
hours, 24 hours, 48 hours, 72 hours, 96 hours, and at
discharge. Renal postoperative dysfunction was defined as
an increase in the serum creatinine greater than 20% of the
preoperative baseline.19 Patients with transient or perma-
nently impaired kidney function and those who demanded
the use of hemofiltration/hemodialysis were recorded.
The follow-up was conducted with a physical exam,
blood tests, and ultrasound scan studies at 6 months, 1
year, and yearly thereafter. All analyzed data were prospec-
tively collected in a computerized database. Descriptive
statistics are given as mean  SD or range, as appropriate,
whereas comparisons between the differences in the two
groups were made using the t test for independent samples
and the Mann-Whitney test, as appropriate. Statistical sig-
nificance was defined at the P  .05 level.
RESULTS
Mean operative time was 220 66 minutes in group A
(JAAA patients) and 231  64 minutes in group B (IAAA
patients) (P  .05). An average of 49  22 minutes were
needed to complete the aorto-iliac laparoscopic dissection
before a suprarenal cross-clamping, compared to 53  26
minutes for the dissection of patients in group B (P .05).
The mean duration of suprarenal cross-clamping was 28 
6 minutes; whereas infrarenal cross-clamping lasted on
average 25  5 minutes (P  .05). Bilateral lower limb
reperfusion occurred after an average of 69 22 minutes in
group A and 72  24 minutes in group B (P  .05). In no
case was the left renal vein interrupted during the dissec-
tion, and an intraoperative cold renal perfusion was never
used.
Mean intraoperative blood loss was 1023 584mL for
group A and 961 633 mL for group B (P .05). Thanks
to the cell saver, only 16.8% of the patients in group A and5.4% in group B required blood transfusions for an average
of 2.7 and 2.4 units, respectively. Conversion to open
surgery during the laparoscopic preparation of the aorta
was never required; in 3 patients in group A (3.6%) and in
11 patients in group B (5.8%), the HALS access incision
was extended caudally to reach the external iliac arteries for
the anastomosis for an additional length of 3 cm, so that the
total length of the wound was 10 cm. A small POLAR renal
artery was reimplanted in 2 patients in group A (2.4%) and
in 1 patient in group B (0.5%). All patients were extubated
immediately after surgery on the operative table. No 30-
day postoperative mortality was recorded in either group.
The average ICU stay in group A was 14.7 16 hours and
14.4 25 hours for group B (P .05). A total of 16.8% of
the patients in group A developed a postoperative compli-
cation vs 11.7% in group B, as detailed in Table III. No
significant difference could be found in the overall rate of
morbidity or in the separate analysis of the incidence of each
complication. A solid diet could always be given to all
patients of both groups on the first postoperative day. Fluid
parenteral support was maintained up to 39.7  13 hours
for patients in group A vs 39.4  17 for those in group B
(P  .05). A total of 3.6% of the patients in group A and
5.3% of the patients in group B required medication to
relieve postoperative pain in addition to the scheduled
treatment (P  .05). Mean postoperative stay for group
A and B was 4.2  1.5 and 4.2  1.9 days, respectively
(P  .05).
Serum creatinine of all the patients in group A increased
during the first 48 hours after surgery, reaching a mean
peak of 9% of the baseline value. Return to preoperative
values occurred after an average of 72 hours. Postoperative
kidney function significantly worsened (serum creatinine
20% of the preoperative level) in 5 patients of group A
(6%), 3 belonging to class c (severe dysfunction), and 2 to
class b (moderate dysfunction). In these patients, serum
creatinine returned to baseline during postoperative day 4.
In patients with preoperative renal insufficiency (all classes),
the incidence of renal dysfunction was 21.4% vs 2.8% in
patients with a normal renal function. No patient in group
A required hemodialysis or hemofiltration despite the su-
Table III. Comparison of postoperative complications of
patients in group A (suprarenal aortic cross-clamping) vs
patients in group B (infrarenal aortic cross-clamping)
Group A Group B P value
Number of patients 83 188
Arrhythmia 5 (6.0%) 6 (3.1%) .715
Myocardial infarction 1 (1.2%) 2 (1.0%) .999
Pneumonia 2 (2.4%) 5 (2.6%) .904
Renal dysfunction* 5 (6.0%) 2 (1.0%) .543
Postoperative bleeding 1 (1.2%) 3 (1.5%) .986
Graft thrombosis 0 1 (0.5%) .904
Prolonged ileus 0 3 (1.5)% .808
Overall incidence of
postop complications 16.8% 11.7% .541
*Creatinine increasing up to 20% of preoperative value.prarenal cross-clamping.
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tion (0.5%) that completely recovered 3 days after surgery.
A relationship was identified between the length of the
warm ischemia time and postoperative renal dysfunction.
For a clamping time shorter than 30 minutes (79.5% of
cases) we encountered only one case of postoperative im-
paired renal function (1.5%). When the suprarenal clamp-
ing time lasted between 30 and 40minutes, which occurred
in 20.5% of our cases, we observed the development of
postoperative renal dysfunction in 4 patients. These 4 pa-
tients also had associated preoperative renal insufficiency (2
in class a, and 2 in class b). Therefore, this pre-existing
condition in our series carried a 25% risk to develop post-
operative renal dysfunction. Also, 1 out of 4 patients with
diabetes in group A developed a transient increase of cre-
atinine.
Follow-up of patients averaged 37.9  20 months.
Midterm mortality was 1 out of 83 (1.2%) and was related
to lung cancer. Renal function deteriorated (20% com-
pared with the value of discharge) in only 1 patient in group
A (1.2%), without evidence of renal artery stenosis (this
patient had normal preoperative and discharge renal func-
tion, suprarenal clamping time was 38 minutes). An iliac
pseudo aneurysm in a patient in group A was detected and
treated by exclusion with a covered stent. Midterm mortal-
ity for patients in group B was of 3 patients out of 188
(1.5%), related to colon and lung cancer in 1 patient each,
and to myocardial infarction in the remaining patient. Two
patients (1%) developed infrainguinal noncritical limb isch-
emia, and 1 patient presented with unilateral renal artery
stenosis without renal function impairment or critical hy-
pertension. All implanted grafts were patent. The incidence
of incisional hernia in group A and B was 15.5% vs 11.1%,
respectively (P  .05).
DISCUSSION
In a previous report, we have shown the potential
benefit and value of HALS to treat a selective group of
patients with AAAs.18 Briefly, the operative technique con-
sists of a preliminary laparoscopic dissection of the aorta,
which is accomplished under video-endoscopic guidance
thanks to a 30° oblique viewing laparoscope. One addi-
tional 5 mm Trocar (Karl Storz Endoscope, Tuttlingen,
Germany) is placed in the left flank and gives access to a
dissecting scissor, whereas exposure and retraction is pro-
vided by the nondominant hand of the operating surgeon,
introduced through the HALS access device placed inside a
midline laparotomy of the length of about 7 cm. Then the
subsequent phases of aortic cross-clamping and graft inter-
position are done with an open approach through the same
minilaparotomy after having set in place a self-retaining
retractor (Fig) and with the aid of long dedicated needle
holders.
Juxtarenal aneurysms pose an additional technical chal-
lenge to the vascular surgeon even in the setting of open
surgery, and for this reason we initially decided to exclude
from the HALS approach patients in need of a suprarenal
cross-clamping. However, after a pilot series of 20 patientswith IAAAs, we realized that with the exposure of the
aneurysmal neck, what we could achieve with the HALS
technique was excellent and also the time needed to control
back-bleeding from the collaterals inside the aneurysm and
perform the proximal graft anastomosis was comparable to
that of the open approach. We therefore started to offer the
HALS option also to patients with juxtarenal aneurysms
and to collect the prospective data that forms the body of
this study. Because we have included all of our early cases in
this report, our data might have been affected by the so
called “learning curve”, favoring the results of the juxtare-
nal aneurysms whose treatment with the HALS technique
was introduced only after the first 20 infrarenal cases.
However, looking more in detail to the results of those
early 20 patients compared to the subsequent series of
infrarenal HALS aneurysms, it seems that the only appre-
ciable – but not statistically significant – difference was in
the length of the laparoscopic dissection, with no signifi-
cant difference in the other outcome measures. Moreover,
considering the first 50 cases, 15 were already juxtarenal
aneurysms requiring a suprarenal clamping.
The two considered groups of patients proved compa-
rable having no significant difference in the analyzed vari-
ables (Tables I and II), except for a higher incidence of
hypertension and mild renal dysfunction in patients of
group A. Analysis of the results of HALS in the two groups
of patients showed no significant difference in operative
time, duration of aortic cross-clamping, blood loss, ICU
stay, resumption of a solid diet, need for parenteral fluid
support, postoperative analgesia requirement, and finally
length of hospital stay. This data provides evidence that the
HALS approach is not only feasible in patients with JAAA,
but also safe, with an outcome similar to that of patients
with IAAA. Time spent in the ICU and postoperative stays
in our patients were even shorter than those reported by
Sarac et al21 in patients undergoing conventional open
surgery. It should be noted that there is currently a cultural
resistance on the part of the patient and his/her family in
our communities to accept a reduction of the hospital
discharge below the threshold of 4 days, which is indeed
frequently perceived as too short in view of the severity of
the underlying disease. The blood loss related to the HALS
technique was still higher in comparison to that of the full
open and mini-incisional approach.5,11 The higher propor-
tion of patients requiring blood transfusions in group A,
despite a substantially equivalent intraoperative blood loss,
can be explained by the relative anemic state of patients
with nephropathy that was compensated intraoperatively.
Although the intraoperative use of a blood recovery
system significantly reduces the need for transfusion, the
development of new devices for a faster control of back-
bleeding aortic collaterals would represent a desirable tech-
nical evolution to limit the amount of blood loss of the
current minimally invasive techniques.
To date, a pure laparoscopic technique to treat patients
with suprarenal aneurysm has been reported only by Cog-
gia et al.22 The potential advantage of his approach is the
capability to perform a two-stage aortic cross-clamping:
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back-flow from the aortic collaterals, then suprarenal to
perform the proximal graft anastomosis. In this way, the
time of renal ischemia is limited to the performance of the
suture between the aorta and the graft. With the HALS
approach, this two-stage aortic cross-clamping is not feasi-
ble due to the limited exposure of the aneurysmal neck area,
once the pneumoperitoneum has been desufflated and the
procedure turns into a minilaparotomy. Although we tried
the technique on a few occasions, the switching between
clamps with a limited view of the aortic neck proved to be
technically very demanding and hazardous, so that we no
longer use it. Although the time of suprarenal cross-clamping
reported by Coggia was shorter than ours (24 minutes), 4
out of his 13 patients developed a transient renal failure
(30%), which compares favorably with the 6% incidence of
this complication in our series, as low as 0.5% in case of
IAAA. The much shorter duration of the pneumoperito-
neum of the HALS technique, in comparison with the pure
laparoscopic approach, might account for this difference.
Indeed, a prolonged pneumoperitoneum is known to re-
duce kidney perfusion23 and experimental evidence has also
been provided to support the physiopathology of this side-
effect of laparoscopy.24 Nonetheless, the well known ben-
efit of the minimally invasive techniques, be these pure
laparoscopy of HALS,8-10 that include a quicker recovery
time, less postoperative pain, earlier return to a normal diet,
reduced infection rate, and shorter hospital stay, might also
have, in combination, a protective effect on renal function.
The mini-incisional technique, first reported by Cerveira
et al5 and Turnipseed et al,11 has never been employed, to
the best of our knowledge, to treat JAAAs. The HALS
approach conversely represents a hybrid technique in that
the initial dissection is accomplished with the help of the
pneumoperitoneum. This is a considerable aid in dissecting
the high neck of a juxtarenal aneurysm, when compared to
the full mini-incisional approach and accounts for the lack
of reports of JAAA managed with the latter technique. We
also believe that using HALS, by offering a direct – trans-
peritoneal – approach to the abdominal aorta and a mini-
incisional open repair, results in a less technically demand-
ing procedure than the pure laparoscopic approach, still
providing the patient most of the benefits of the totally
laparoscopic technique.
We believe that these should be regarded as absolute
contraindications to the HALS technique: all emergencies,
redo aortic surgery, massive calcified walls at the clamping
or anastomotic sites, and concomitant aneurysms of the
hypogastric arteries. Relative contraindications are: previ-
ous major abdominal surgery, and patients with severe
respiratory disease that might not tolerate the 12 mm Hg
positive pressure of CO2 pneumoperitoneum of the HALS
technique. In all of the above circumstances, our choice
would be in favor of the conventional open technique. In
our practice, the choice between the various available treat-
ments (EVAR, HALS, minilaparotomy, or open surgery) is
taken collegially during the weekly case discussion by all the
surgeons of the unit. The EVAR treatment is reserved topatients with the appropriate anatomical features, or in the
presence of high risk for other approaches. The decision
betweenHALS andminilaparotomy is todaymainly depen-
dant on the availability of surgeons with sufficient experi-
ence with laparoscopy, rather than on the patient’s related
factors. At present, half of our vascular surgeons have been
fully trained in this technique; additionally, two other sur-
geons from other hospitals have been trained in Pisa, Italy,
and are running independent programs of HALS aortic
surgery.
The recent application of endovascular therapy also for
JAAA has the potential to further reduce the trauma of
access to these patients. However, a 16% incidence of
periprocedural renal dysfunction was reported after EVAR
in patients with a previously normal renal function and as
high as 39% in those with pre-existing renal insufficiency.25
Nonetheless, it should be considered that current candi-
dates for fenestrated endografting are only patients ex-
cluded from open surgery in view of their high risk, which
are, therefore, not comparable to those undergoing HALS
repair in the present series.
Midterm results in patients in group A did not show
any significant worsening of the renal function and only 1
patient out of 83 required additional surgery for a graft-
related complication. The high rate of incisional hernia at
the HALS access site in both groups still represents an open
problem with this technique.
In conclusion, our study provides evidence that the
HALS technique can be safely adopted also for the treat-
ment of patients with JAAAwith an outcome similar to that
of patients with IAAA. The video-endoscopic preparation
of the suprarenal aortic segment is easier than expected with
an excellent visual control of this area. This technique does
not increase the risk of postoperative or midterm renal
damage or the incidence of other major complications.
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